Volume : 09, Issue : 09, September – 2022
Title:
11.PREPARATION AND CHARACTERIZATION OF INDOMETHACIN-LOADED CHITOSAN NANOPARTICLES
Authors :
Vothani Sarath Babu*, Prudhvi Guru Yachendhra , Karra Naga Venkata Sai Raju , Chippada Appa Rao
Abstract :
The aim of the present study involves the preparation and characterization of chitosan loaded Indomethacin nanoparticles. The possibility to achieve a therapeutic dose was much higher by using the Prepared Nanoparticles. The prepared Indomethacin chitosan loaded nanoparticles would be capable of reducing the frequency of administration and the dose-dependent side effects associated with the repeated administration of conventional Indomethacin tablets. Out of all the prepared formulations F3 with the Indomethacin concentration of 40mg showed the highest entrapment efficiency of 81.25 % when compared to that of other formulations and the highest extent of release (79.9%). The Chitosan-NPs based controlled delivery system developed in this study would have potential applications and could serve as an optimal model to encapsulate any hydrophilic or hydrophobic therapeutic agent, vitamins, probiotics, enzeymes, flavors, fatty acids, antimicrobial agents and peptides etc.
Key word:
Cite This Article:
Please cite this article in press Vothani Sarath Babu et al, Preparation And Characterization Of Indomethacin-Loaded Chitosan Nanoparticles., Indo Am. J. P. Sci, 2022; 09(9).
Number of Downloads : 10
References:
1. 1. Cristina Buzea, Ivan Pacheco, Kevin Robbie., Nanomaterials and Nanoparticles: Sources and Toxicity.,Biointerphases.,2007; 2:10- 22.
2. Paul JA, Borm and Wolfgang Kreyling., Toxicological Hazards of Inhaled Nanoparticles- Potential Implications for Drug Delivery., J Nanosci Nanotech., 2004; 4(6):1-11.
3. Agnihotri, S. A., Mallikarjuna, N. N., and Aminabhavi, T. M., Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J. Control. Rel., 2004; 1( 5)-14- 28
4. Ammoury, N., Fessi, H., Devissagguet, J. P., Puisieux, F., and Benita, S., In vitro release kinetic pattern of indomethacin from poly (D,L-lactide) nanocapsules. J. Pharm. Sci., 2001; 79, 763-767.
5. Kruparani* et.al., Review of Nanoparticles., Journal of Pharmaceutical Sciences., 2020: 5(6): 15- 32.
6. Rezaei Mokarram,* et.al., Preparation and in-vitro evaluation of indomethacin nanoparticles., Jurnal of Pharmaceutical Sciences., 2015; 18(3): 185–192.
7. Waisudin Badri,* et.al., Elaboration of Nanoparticles Containing Indomethacin: Argan Oil for Transdermal Local and Cosmetic Application., Journal of Nanomaterials., 2014: 7(2): 1452-1467.
8. Yoshitha*et.al., Indomethacin-loaded redox nanoparticles improve oral bioavailability of indomethacin and suppress its small intestinal inflammation., Journal of Therapeutic Delivery., 2013:5(2):1177-1198.
9. Kumar*et.al., In-Vitro and In-Vivo Study of Indomethacin Loaded Gelatin Nanoparticles., Journal of Biomedical Nanotechnology., 2013:7(3): 1290-1310.
10. Asifa*et.al., Utilization of Crosslinked Starch Nanoparticles as a Carrier for Indomethacin and Acyclovir Drugs., Journal of Nanomedicine and Nanotechnology., 2012:4(5): 1586-1595.
11. M. Mohan Varma *., A Review On Nanoparticles: Synthesis, Characterization And Applications., World Journal Of Pharmaceutical And Medical Research.,2021; 7(8):169-179.
12. Ananta Choudhury * et.al., A Review on Nanoparticle: Types, Preparation and its Characterization., Research Journal of Pharma and Technology., 2020: 14(3): 1815-1822.
13. Beena Kumari*., A Review On Nanoparticles: Their Preparation Method And Applications., Indian Research Journal Of Pharmacy And Science., 2019; 5(2):1420-1427.
14. Swathi Rani Samanta* et.al., A review on properties, application and toxicity of of Nanoparticles., world journal of pharmacy and pharmaceutical sciences., 2018;10(8): 957-971.
15. T. Higuchi, Mechanism of Sustained-Action Medication. Theoretical Analysis of Rate of Release of Solid Drugs Dispersed in Solid Matrices, J Pharm Science., 2011;5(3):1145-9.
16. J. Siepmann and A. Gopferich, Mathematical modeling of bioerodible, polymeric drug delivery systems., Advance Drug Delivery and Research., 2001; 4(8): 229-47.
17. J. Siepmann, F. Lecomte and R. Bodmeier, Diffusion-controlled drug delivery systems: calculation of the required composition to achieve desired release profiles., Journal of Control Release., 2000; 6(5):379-89.
18. MitraJelvehgari, JalehBarar, HadiValizadeh, NasrinHeidari. Preparation and Evaluation of P ε-caprolactone) Nanoparticles-in-Microparticles by W/O/W Emulsion Method. Iranian Journal of Basic Medical Sciences, 2010; 9(1): 25-35